Platinum is essential in neoadjuvant treatment of triple-negative breast cancer: a network meta-analysis
Objective: This study aimed to assess the efficacy and safety of various neoadjuvant regimens for patients diagnosed with early-stage or locally advanced triple-negative breast cancer (TNBC). Methods: Medline, EMBASE, Cochrane Library, and Web of Science were searched in May 2020 to identify randomi...
Main Authors: | Junjie Li, Li Chen, Wei Tan, Fang Qi, Yang Zhang, Zhonghua Wang, Zhimin Shao |
---|---|
Format: | Article |
Language: | English |
Published: |
China Anti-Cancer Association
2022-05-01
|
Series: | Cancer Biology & Medicine |
Subjects: | |
Online Access: | https://www.cancerbiomed.org/content/19/5/742 |
Similar Items
-
Neoadjuvant therapy in triple-negative breast cancer: A systematic review and network meta-analysis
by: Ying-Yi Lin, et al.
Published: (2022-12-01) -
Efficacy of platinum-based and non-platinum-based drugs on triple-negative breast cancer: meta-analysis
by: Canling Lin, et al.
Published: (2022-10-01) -
Survival outcomes of neoadjuvant versus adjuvant chemotherapy in triple-negative breast cancer: a meta-analysis of 36,480 cases
by: Lin-Yu Xia, et al.
Published: (2020-06-01) -
Current status and novel directions in triple negative breast cancer patients. Risk factors. Role of the platinum-based chemotherapy
by: Olivia IONESCU, et al.
Published: (2016-06-01) -
Neoadjuvant Treatment for Triple Negative Breast Cancer: Recent Progresses and Challenges
by: Jin Sun Lee, et al.
Published: (2020-05-01)